Atlas Trials

Avelumab for MSI-H or POLE Mutated Metastatic Colorectal Cancer

Clinical trial NCT03150706 · UNKNOWN

Trial details

NCT number
NCT03150706
Sponsor
Asan Medical Center
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2017-05-22
Primary completion
2021-07-31
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.